GlassScriptPhysician profile
Leoncio Gonzalez
NPI 1356333900
$3,988.83
in general payments reported to CMS, 2019-2025
20 companies · $510 in 2025
The $510 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $525 · 2020: $735 · 2021: $173 · 2022: $567 · 2023: $694 · 2024: $786 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927 · Entertainment: $62.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,926.73 |
| Entertainment | $62.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $484.81 | 2023-2025 | Infuse |
| Visioneering Technologies, INC. | $445.68 | 2019-2020 | |
| Abb Con-Cise Optical Group LLC | $421.71 | 2019-2020 | |
| Oyster Point Pharma, INC. | $353.47 | 2022-2025 | Tyrvaya |
| Alcon Vision LLC | $322.54 | 2024-2025 | Rocklatan, Rhopressa, Precision 1 |
| Tarsus Pharmaceuticals, INC. | $293.71 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $293.53 | 2020-2021 | |
| Coopervision INC. | $247.55 | 2019-2025 | Rose K Contact Lens, Myday Contact Lens, Synergeyes Contact Lens |
| Johnson & Johnson Vision Care, INC. | $194.53 | 2022-2025 | Acuvue |
| Lombart Brothers, INC. | $156.97 | 2022-2024 | Opd-III |
| Sun Pharmaceutical Industries INC. | $154.83 | 2020-2023 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $135.51 | 2023 | Lipiflow System Activator (Disposable) |
| Sight Sciences, INC. | $123.58 | 2022 | |
| Maculogix, INC. | $114.61 | 2020 | |
| Novartis Pharmaceuticals Corporation | $73.77 | 2019-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $62.32 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Rxsight INC | $38.46 | 2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Dompe US, INC. | $27.00 | 2024 | Oxervate |
| Shire North American Group INC | $23.01 | 2019 | |
| Astellas Pharma US INC | $21.24 | 2024 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leoncio Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.